Biomarkers Market (Diagnostic Applications in Risk Assessment, Molecular Diagnostics, Disease Diagnosis, Drug Discovery & Development, Drug Formulation, Forensic Applications and Others) – Global Industry Analysis, Emerging Technologies, Competitive Intelligence, Growth Trends, Size, Share, Opportunities and Forecast, 2013 – 2020

Date: 2015-05

“Biomarker technology is evidencing increased application from key segments such as disease diagnosis, drug development and formulation, diagnosis for exposure of certain harmful chemical and prognostic treatments. Biomarkers are novel diagnostic solutions and advancement in it its development and understanding of human genome promotes its application in diagnosis of disease on molecular basis. Pharmaceutical companies which are interested in introducing novel diagnostic solution are increasing partnership and collaboration with private laboratories, educational institute and these companies are also increasing their investments in research and development.

The global market for diagnostic biomarker expected to reach about $30.6 billion in 2020 growing at CAGR of 16% from 2013 to 2020. Disease diagnostic application remains the key area of application that is expected to reach 6.1 $billion in 2020. However application of diagnostic biomarkers in forensics and molecular diagnostics is catching up quite significantly. Molecular diagnostics is expected to grow at a CAGR of 17.6% from 2013 to 2020.


Global diagnostic Biomarker report segments the market in three categories; market by technologies, market by services, and market by diseases. These markets are expected to show elevated growth in future as biomarkers are providing diagnostic service for complex disease. As it is non-invasive procedure it motivates the use of biomarkers than conventional diagnostic applications. This report focuses on key factors impacting the diagnostic biomarker market used in risk assessment, molecular diagnostics, disease diagnosis, drug discovery and development, drug formulation, forensic applications and others. Diagnostic biomarker and its applications in emerging segments of omics, imaging technologies, personalized medicine, and bioinformatics are all discussed in detail.

Key deliverables

Biomarkers of disease are majorly covered by oncology, cardiovascular and Neurology disease. Oncology biomarkers are covering more market share as compared to other disease biomarkers. Other biomarker are facing some ethical and technical problem such complex sample preparation process.

Biomarkers in service has open a new market for sample preparation for disease diagnosis which enables clinicians to save time required for preparing sample to conduct diagnostic test. Biomarkers are also resolving drug validation problem by analyzing viability of drug discovered by pharmaceutical research.

The geographic analysis is based on North America., Europe, Asia-Pacific and Rest of the World.

The key players in this market that are also profiled in the report include Roche Diagnostic Limited (Switzerland), Siemens Healthcare (Germany), Abbott Laboratories Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), Aushon BioSystem Inc. (M.A.), Epistem Ltd.(U.K.), G.E. Healthcare Inc.(U.K).

Key benefits of report

Assessment and ranking the factors that favour the market growth and those factors which act as a hindrance for the growth of the market
The market sizing and estimation period is from 2013 to 2020. Two historic years include 2011 and 2012
The report identifies and analyses top investment pockets and top winning strategies for diagnostic biomarker market
The report analyses the various strategies adopted by some of the key companies in the market
The report tracks and analyses key innovations and patents for biomarkers in the last five years”

Contact With Us
Join templatemonster at google+
Customized Research
Request Sample